Health Condition 1: I10- Essential (primary) hypertension Health Condition 2: J44- Other chronic obstructive pulmonary disease Health Condition 3: E11- Type 2 diabetes mellitus
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: -Medically stable elderly individuals aged 60-80 years diagnosed with one or more noncommunicable diseases (E.g. hypertension, diabetes, hypercholesteremia, bronchial asthma, chronic obstructive lung disease) -Prescribed with three or more oral medications for at least past 6 months and are able to self-administer the medications. b. Planning to stay in the study area for next one year. c. Access to a smartphone within the family throughout the day and knowledge to use it. d. Willing to participate in the study.
Exclusion criteria
Exclusion criteria: -History of hospitalisation during last one month -Individuals diagnosed with any mental or cognitive dysfunction (e.g. Schizophrenia, Alzheimerâ??s disease) -Individuals with expected life expectancy of less than one year (e.g. severe debility due to advanced age, advanced stage malignant cancers) -Used pill organiser or pill reminder app for improving medication adherence in the past. -Any other condition that in the opinion of the investigator jeopardises the health and wellbeing of the participant in case of participation.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Assessment of medication adherence using Medication adhrence rating system - 5 (MARS-5), Self reported seven days point prevalence of medication non-adherence and pill count.Timepoint: MARS-5 and seven days point prevelence of medication non-adhrence will be assessed at 3, 6 and 12 months. Pill counts will be assessed at the end of each quarter during 12 months follow up. | — |
Secondary
| Measure | Time frame |
|---|---|
| Assessment of acceptability and barriers for the use of manual pill organisers and pill reminder appsTimepoint: The acceptability and barriers will be evaluated through the qualitative study in phase 1. Additionally, systems usability scale (SUS) will be used for assessment of usability of the manual pill organisers and pill reminder app.;Health care utilisationTimepoint: Number of hospitalisation or emergency department visits or outpatient visits or general practitioner visits will be measured at 3,6 and 12 months;Adverse clinical outcomesTimepoint: Any clinically significant events that may impact on healthcare utilisation and mortality (at 3, 6 and 12 months);Quality of Life, cost effectiveness & cost-utility ratioTimepoint: Quality of life will be assessed at baseline & 12 months using EQ5D5L. Cost for development of each study intervention will be calculated. Cost-effectiveness will be calculated against the primary outcome of medication adherence. The incremental cost-utility ratio will be calculated as additional cost required to have unit change in the quality of life. | — |
Countries
India
Contacts
Vadu Rural Health Program, KEM Hospital Research centre